Algecal® Jr. Tablet: Each chewable tablet contains Calcium Carbonate (Algae source) 250 mg.
Algecal® Jr. is the combination of Ocean based Algae source Calcium. Algae source Calcium is extracted from *Algas Calcarea*, a red Algae found in the shores of South America. Algae source Calcium ensures better absorption than Coral source Calcium or other Calcium Carbonate due to its fibrous chemical structure.
Mode of action:
Calcium is absorbed in the intestine which then passes through the intestine to blood & deposited into bone.
Pharmacokinetics:
75% of Calcium from Algae source is absorbed in the intestine. In a USP dissolution test (simulating stomach condition) 97% of Calcium from Algae source goes into the solution.
Algecal® Jr. is indicated for osteogenesis, osteomalacia, hypoparathyroidism, rickets & brain development. It can also be used as supplement in case of inadequate intake of Calcium in childhood diet, pregnancy & lactation & poor absorption during old age. Other indications include pancreatitis & phosphate binder in chronic renal failure etc.
1 tablet once or twice daily or as directed by the physician.
Major interaction: Administering intravenous Ceftriaxone & Calcium can result in life-threatening damage to the lungs & kidneys. Calcium should not be administered intravenously within 48 hours of intravenous ceftriaxone.
Minor interaction: Calcium can reduce the absorption of tetracycline & fluoride preparations and minimum 3 hours time should be allowed between ingestion of these medications. Thiazide diuretics reduce the renal excretion of Calcium. Intake of certain foods like spinach, cereals, milk and its derivatives may reduce the intestinal uptake of Calcium.
In mild hypercalciuria, reduction of dose should be sufficient to return to normal serum Calcium concentration. Patients with kidney stone or with such previous history should be recommended to increase their fluid intake.
Keep out of reach of children. Store in a dry place, below 25°C temperature and protected from light.